Gene: MYO1D
Official Full Name: myosin IDprovided by HGNC
Gene Summary: Enables protein domain specific binding activity. Predicted to be involved in several processes, including actin filament organization; actin filament-based movement; and early endosome to recycling endosome transport. Located in extracellular exosome. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36508 | MYO1D Knockout cell line (HCT 116) | Human | MYO1D | 1:2~1:4 | Negative | Online Inquiry |
KO36509 | MYO1D Knockout cell line (HEK293) | Human | MYO1D | 1:3~1:6 | Negative | Online Inquiry |
KO36510 | MYO1D Knockout cell line (A549) | Human | MYO1D | 1:3~1:4 | Negative | Online Inquiry |
MYO1D Gene Knockout Cell Lines represent a groundbreaking advancement in the field of genetic research, specifically designed to facilitate the in-depth study of the MYO1D gene, a member of the myosin superfamily. These knockout cell lines have been genetically engineered to disrupt the MYO1D gene’s function, thus allowing researchers to investigate its role in various biological processes, including cellular motility, signal transduction, and muscle function. By providing a controlled experimental model, these cell lines enable a more nuanced understanding of how MYO1D contributes to health and disease.
The primary mechanism of action for MYO1D Gene Knockout Cell Lines involves the absence of the MYO1D protein, which is integral to actin-based motility processes. By eliminating this protein, researchers can observe phenotypic changes in cellular behavior, including alterations in migration patterns and intracellular trafficking. This knockout approach is critical for elucidating gene function and can aid in unraveling molecular pathways implicated in various conditions, such as muscular disorders and certain cancers.
In the context of scientific research and clinical applications, these MYO1D Gene Knockout Cell Lines provide an invaluable resource for drug discovery, biomarker identification, and the exploration of genetic interactions. Their use allows for the identification of compensatory mechanisms that may arise in the absence of MYO1D, giving deeper insight into potential therapeutic targets.
Unlike traditional cell lines, which may express varying levels of MYO1D protein, our knockout line presents a pure model lacking this gene, thus ensuring experimental accuracy and reliability. This specificity helps to minimize background noise and variability, which are often encountered when utilizing wild-type lines. As a result, researchers can achieve more consistent and reproducible outcomes, making these cell lines a unique asset for any laboratory focused on cellular and molecular biology.
For researchers and clinicians who require precise models to conduct groundbreaking studies, MYO1D Gene Knockout Cell Lines represent a critical tool. With our extensive expertise in genetic engineering and a commitment to providing high-quality biological products, our offerings empower the scientific community to push the boundaries of discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.